NUR 210 Final Exam Q&A (50+) – CNS Depressants, Pain Meds, Anticonvulsants | 2025/2026

This document is a complete NUR 210 – Pharmacology in Nursing Practice final exam review for the 2025/2026 academic year from [Example University]. It contains over 50 multiple-choice questions with correct answers and focused rationales, tailored to help nursing students solidify their understanding of high-yield pharmacological topics. Core subjects include: Benzodiazepines (e.g., lorazepam, diazepam, alprazolam, midazolam): indications, side effects, antidotes, and patient safety teaching CNS depressants and sleep aids (e.g., zolpidem) Local and regional anesthetics (e.g., lidocaine, epidural protocols) NSAIDs and pain management (e.g., aspirin, celecoxib, acetaminophen) Opioid pharmacology (e.g., morphine sulfate, naloxone use) CNS stimulants and ADHD meds (e.g., methylphenidate) Anticonvulsants and mood stabilizers (e.g., valproic acid, phenytoin, phenobarbital) Each entry includes drug classifications, therapeutic uses, side effects, adverse reactions, contraindications, lab monitoring, and nursing teaching points. This is ideal for quick review before exams or for clinical reference. Recommended for: Students in NUR 210 or equivalent pharmacology-focused courses ADN/BSN nursing students in their first or second year NCLEX-RN or ATI prep candidates needing a pharmacology refresher Nursing educators looking for focused question sets to assess drug knowledge International nurses preparing for U.S. licensure exams Keywords: NUR 210, pharmacology, CNS depressants, benzodiazepines, anticonvulsants, sleep meds, pain management, NSAIDs, opioids, mood stabilizers, nursing drugs, NCLEX pharmacology, ATI pharm, drug side effects, nursing med review